|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
11.970 +0.790 (+7.066%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 2,531,632 | 8.776% | 2,327,382 | 2,170,339 | 2,138,952 | 1,931,212 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | 1,585,066 | 35.718% | 1,167,912 | 858,260 | 552,684 | 232,479 |
| Interests in Asso. & JCEs | 162,900 | 6.323% | 153,212 | 150,571 | 9,455 | 9,265 |
| Other Non-current Assets | 3,056,264 | 24.281% | 2,459,156 | 2,035,553 | 2,629,409 | 3,008,638 |
| 7,335,862 | 20.109% | 6,107,662 | 5,214,723 | 5,330,500 | 5,181,594 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 589,495 | -0.720% | 593,769 | 614,562 | 304,780 | 235,157 | |
| Trade Receivables | 2,838,454 | 5.135% | 2,699,825 | 2,631,645 | 2,338,830 | 2,398,767 | |
| Cash & Bank Balances | 3,512,088 | 79.869% | 1,952,586 | 2,007,162 | 1,658,312 | 973,139 | |
| Other Current Assets | 449,734 | 82.813% | 246,008 | 385,575 | 1,156,530 | 1,372,486 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 7,389,771 | 34.551% | 5,492,188 | 5,638,944 | 5,458,452 | 4,979,549 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 249,032 | -9.792% | 276,064 | 317,218 | 335,433 | 323,951 | ||
| S-T Debt & Leases | 1,109,819 | -0.794% | 1,118,698 | 1,094,981 | 1,350,823 | 1,561,643 | ||
| Other Current Liabilities | 1,986,198 | 48.900% | 1,333,915 | 1,273,701 | 1,280,362 | 1,178,169 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 3,345,049 | 22.589% | 2,728,677 | 2,685,900 | 2,966,618 | 3,063,763 | |||
| Net Current Assets | 4,044,722 | 46.362% | 2,763,511 | 2,953,044 | 2,491,834 | 1,915,786 | ||
| Total Assets Less Current Liabilities | 11,380,584 | 28.287% | 8,871,173 | 8,167,767 | 7,822,334 | 7,097,380 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 77,114 | -14.952% | 90,671 | 334,243 | 155,921 | 74,239 | |||
| Other Non-current Liabilities | 1,888,880 | 14.712% | 1,646,625 | 610,788 | 518,641 | 560,384 | |||
| 1,965,994 | 13.164% | 1,737,296 | 945,031 | 674,562 | 634,623 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 4,618,517 | 45.520% | 3,173,805 | 3,173,805 | 3,081,131 | 3,002,871 | ||||
| Reserves | 4,789,349 | 20.941% | 3,960,072 | 4,048,931 | 4,050,579 | 3,434,126 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 9,407,866 | 31.876% | 7,133,877 | 7,222,736 | 7,131,710 | 6,436,997 | ||||
| Non-controlling Interests | 6,724 | -- | 0 | 0 | 16,062 | 25,760 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 9,414,590 | 31.970% | 7,133,877 | 7,222,736 | 7,147,772 | 6,462,757 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 436,784 | 586,333 | 281,749 | 112,677 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 27/03/2026 10:14 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,344,008 |
| %Change | 86.150% |
| EPS / (LPS) | RMB 0.540 |
| NBV Per Share (¥) | RMB 3.624 |